Charlene Smith, APRN
Adult Health · West Columbia, SCNPI 1568187961
Payments from drug & device makers
Across 137 payments — averaging $21.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$693
- Novartis$225
- Neurocrine Biosciences, Inc.$210
- Acadia Pharmaceuticals Inc$207
- Lundbeck LLC$177
- Pfizer$169
- plus $1K from 27 others
What the payments were for
- Food & beverage$2,78996%
- Education$1304%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 39 | $693 |
| Novartis | 8 | $225 |
| Neurocrine Biosciences, Inc. | 9 | $210 |
| Acadia Pharmaceuticals Inc | 8 | $207 |
| Lundbeck LLC | 7 | $177 |
| Pfizer | 10 | $169 |
| Teva Pharmaceuticals USA, Inc. | 4 | $128 |
| TG Therapeutics, Inc. | 5 | $110 |
| AstraZeneca(2 entities) | 5 | $93 |
| Eisai Inc. | 4 | $88 |
| UCB, Inc. | 4 | $83 |
| Neurelis, Inc. | 3 | $59 |
| EMD Serono, Inc. | 1 | $58 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| Argenx US, Inc. | 3 | $58 |
| Genentech USA, Inc. | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| Catalyst Pharmaceuticals, Inc. | 2 | $49 |
| Lilly USA, LLC | 3 | $43 |
| Sanofi | 1 | $30 |
| Amylyx Pharmaceuticals, Inc. | 1 | $29 |
| Insightec,inc | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| Jazz Pharmaceuticals Inc. | 1 | $24 |
| CSL Behring | 1 | $23 |
| Amneal Pharmaceuticals LLC | 1 | $23 |
| Tanabe Pharma America, Inc. | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $21 |
| Mallinckrodt Hospital Products Inc. | 1 | $19 |
| Hospira, Inc. | 1 | $18 |
| Springworks Therapeutics, Inc. | 1 | $16 |
| Impel Pharmaceuticals Inc. | 1 | $15 |
| Amgen | 1 | $15 |
How this compares
$2,920 in reported general payments places this provider in the 70th percentile of 292 adult health providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 45 | $345,372 |
| PanzygaImmun Glob G(Igg)-Ifas/Glycine | 36 | $291,732 |
| NuplazidPimavanserin Tartrate | 14 | $68,100 |
| Emgality PenGalcanezumab-Gnlm | 41 | $39,535 |
| UbrelvyUbrogepant | 31 | $33,076 |
| Nurtec OdtRimegepant Sulfate | 26 | $30,249 |
| Aimovig AutoinjectorErenumab-Aooe | 36 | $25,845 |
| FycompaPerampanel | 17 | $25,146 |
| QuliptaAtogepant | 20 | $23,920 |
| NeuproRotigotine | 18 | $15,022 |
| Levetiracetam | 225 | $9,055 |
| Memantine Hcl | 250 | $6,579 |
| Lacosamide | 64 | $6,414 |
| Memantine Hcl ErMemantine Hcl | 79 | $6,041 |
| Rivastigmine | 35 | $4,759 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $210 | $345,37245 claims |
| PfizerPanzyga, Nurtec Odt | $169 | $321,98162 claims |
| Acadia Pharmaceuticals IncNuplazid | $207 | $68,10014 claims |
| AbbVieUbrelvy, Qulipta | $693 | $56,99651 claims |
| Eisai Inc.Fycompa | $88 | $25,14617 claims |
| UCB, Inc.Neupro | $83 | $15,02218 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 292 adult health providers in South Carolina.
Other adult health in West Columbia
- Andrea OlsonWest Columbia$12K
- Christi WigginsWest Columbia$10K
- Leslee AunWest Columbia$8K
- Susan GriffinWest Columbia$8K
- Jennifer PeaglerWest Columbia$8K
- Latoya HintonWest Columbia$7K
- Shannon HallmanWest Columbia$7K
- Natalie O'KellyWest Columbia$7K
- Haleigh TaylorWest Columbia$6K
- Cecilia PorcherWest Columbia$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.